Results 21 to 30 of about 18,040 (170)

Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines

Vaccines, 2020
Safety, efficacy, and cost-effectiveness are paramount to vaccine development. Following the isolation of rotavirus particles in 1969 and its evidence as an aetiology of severe dehydrating diarrhoea in infants and young children worldwide, the quest to ...
Olufemi S Folorunso, Olihile M Sebolai
exaly   +3 more sources

Recommendations for Rotavirus Vaccine

Pediatrics and Neonatology, 2013
Rotavirus infection has been the leading cause of gastroenteritis among children in Taiwan. Studies have shown that 40% of hospitalization for acute gastroenteritis can be prevented through the use of vaccines, including a live, attenuated monovalent ...
Ping-Ing Lee, Po-Yen Chen, Yhu-Chering Huang, Chin-Yun Lee, Chun-Yi Lu, Mei-Hwei Chang, Yung-Zen Lin, Nan-Chang Chiu, Yen-Hsuan Ni, Chung-Ming Chen, Luan-Yin Chang, Ren-Bin Tang, Li-Min Huang, Yung-Feng Huang, Kao-Pin Hwang, Betau Hwang, Tzou-Yien Lin   +16 more
doaj   +3 more sources

Indirect protection from rotavirus vaccines: a systematic review [PDF]

Expert Review of Vaccines
Introduction Rotavirus vaccines may provide indirect protection by reducing transmission in the population and thus reducing disease burden.Methods This systematic review summarizes estimates of indirect protection from rotavirus vaccines and the methods
Tyler Chavers, Jordan Cates, Eleanor Burnett, Umesh D. Parashar, Jacqueline E. Tate   +4 more
doaj   +2 more sources

Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?

Human Vaccines and Immunotherapeutics, 2019
Rotavirus vaccines have been introduced into over 95 countries globally and demonstrate substantial impact in reducing diarrheal mortality and diarrheal hospitalizations in young children.
A Duncan Steele, U D Parashar
exaly   +2 more sources

Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study [PDF]

Human Vaccines and Immunotherapeutics, 2022
Frédéric Debellut, Clint Pečenka, William P Hausdorff   +2 more
exaly   +2 more sources

Established and new rotavirus vaccines: a comprehensive review for healthcare professionals [PDF]

Human Vaccines and Immunotherapeutics, 2022
Volker Vetter, Bernd Benninghoff, Priya Pereira   +2 more
exaly   +2 more sources

National stakeholder preferences for next-generation rotavirus vaccines: Results from a six-country study [PDF]

Vaccine, 2022
Jessica Price, Jessica Mooney, Carolyn Bain   +2 more
exaly   +2 more sources

Genetic characterization of G12P[6] and G12P[8] rotavirus strains collected in six African countries between 2010 and 2014

BMC Infectious Diseases, 2021
Background G12 rotaviruses were first observed in sub-Saharan Africa in 2004 and since then have continued to emerge and spread across the continent and are reported as a significant human rotavirus genotype in several African countries, both prior to ...
Kebareng G. Rakau, Martin M. Nyaga, Maemu P. Gededzha, Jason M. Mwenda, M. Jeffrey Mphahlele, L. Mapaseka Seheri, A. Duncan Steele   +6 more
doaj   +1 more source

Results and prospects of rotavirus immunisation in the Russian Federation

Биопрепараты: Профилактика, диагностика, лечение, 2023
Scientific relevance. Rotavirus disease and its consequences remain a leading vaccine-preventable cause of mortality in young children. Russia has not yet included rotavirus immunisation in the national vaccination schedule, but paediatric rotavirus ...
A. S. Korovkin, G. M. Ignatyev
doaj   +1 more source

Understanding Rotavirus Vaccine Efficacy and Effectiveness in Countries with High Child Mortality

Vaccines, 2022
Rotavirus claims thousands of lives of children globally every year with a disproportionately high burden in low- and lower-middle income countries where access to health care is limited.
Tintu Varghese, Gagandeep Kang, Andrew Duncan Steele   +2 more
doaj   +1 more source